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Background. The development of new high-throughput genotyping technologies has allowed fast evaluation of single
nucleotide polymorphisms (SNPs) on a genome-wide scale. Several recent genome-wide association studies employing these
technologies suggest that panels of SNPs can be a useful tool for predicting cancer susceptibility and discovery of potentially
important new disease loci. Methodology/Principal Findings. In the present paper we undertake a careful examination of
the relative significance of genetics, environmental factors, and biases of the data analysis protocol that was used in
a previously published genome-wide association study. That prior study reported a nearly perfect discrimination of esophageal
cancer patients and healthy controls on the basis of only genetic information. On the other hand, our results strongly suggest
that SNPs in this dataset are not statistically linked to the phenotype, while several environmental factors and especially
family history of esophageal cancer (a proxy to both environmental and genetic factors) have only a modest association
with the disease. Conclusions/Significance. The main component of the previously claimed strong discriminatory signal is
due to several data analysis pitfalls that in combination led to the strongly optimistic results. Such pitfalls are preventable and
should be avoided in future studies since they create misleading conclusions and generate many false leads for subsequent
research.
Citation: Statnikov A, Li C, Aliferis CF (2007) Effects of Environment, Genetics and Data Analysis Pitfalls in an Esophageal Cancer Genome-Wide
Association Study. PLoS ONE 2(9): e958. doi:10.1371/journal.pone.0000958
INTRODUCTION
One of the promising methods for analysis of the human genome
and identification of genes and genomic regions contributing to
phenotypes is the use of single nucleotide polymorphisms (SNPs).
SNPs make up more than 90% of all human genetic variation and
have been extensively studied for functional relationships between
genotype and phenotype. The advent of high-throughput
genotyping technologies has allowed fast evaluation of SNPs on
a genome-wide scale at a relatively low cost [1–3].
During the last two years several groups reported success in
using SNP genotyping assays in association studies of cancer [1,4–
8]. In particular, the study by Hu et al. reported a nearly perfect
classification of esophageal cancer cases and controls on the basis
of only SNP data from a case-control genome-wide association
study [8]. Taken at face value, this result suggests that esophageal
cancer is a solely genetic disease. This is contradictory to other
literature in the field that emphasizes importance of environment
for cancer susceptibility [9,10]. In order to shed light on this issue,
we re-analyzed the data of [8].
We identified two data analysis pitfalls in [8] that caused over-
optimistic conclusions in the original paper: First, the SNP
selection method was severely biased toward claiming significance
for SNPs that are not truly associated with the disease. Second,
both SNP selection and building of classifier model were
performed on the same subjects as used for estimation of
classification accuracy. Since neither cross-validation nor in-
dependent sample validation were performed, the resulting
classification performance estimate was overoptimistic.
We conducted a re-analysis of the SNP and environmental data
that corrects the above problems and found that the SNPs in this
dataset are not statistically linked to esophageal cancer, while
several environmental factors, especially family history of esoph-
ageal cancer (that potentially accounts for many environmental
and genetic factors), have a modest association with the disease.
We quantified the contribution of each of the factors to cancer
classification and provided unbiased classification performance
estimates using established unbiased data analysis protocols. Given
the insignificant contribution of SNPs to cancer classification, our
findings suggest that the SNPs identified in [8] lack statistical
evidence for being involved in esophageal cancer.
MATERIALS AND METHODS
In all data analyses in addition to replicating the methods of [8],
we used unbiased alternatives so that the effects of bias (if any) in
the analysis of [8] could be quantified. The justification of
unbiasedness of alternative methods is provided in the pertinent
subsections below.
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The data used in the present study is the same as used in the original
paper [8]. The data consisted of 50 esophageal squamous cell
carcinoma patients and 50 controls. The patients were diagnosed
with esophageal cancer between 1998 and 2000 in Shanxi Cancer
Hospital in Taiyuan, People’s Republic of China. Twenty-five
patientsand nine controlshad a positive familyhistory of the disease.
The controls were matched by age, sex, and place of residence.
The genotyping of venous blood samples for all subjects in the
study was performed at the National Cancer Institute (Bethesda,
Maryland) as summarized below: The germ line DNA was
extracted and purified. DNA samples were subsequently prepared
and assayed according to Affymetrix GeneChip Mapping Assay
protocol. The 10K SNP arrays with 11,555 SNPs distributed
throughout human genome were scanned and genotype calls were
assigned automatically by the Affymetrix GeneChip DNA Analysis
software. Four genotype calls were defined in the data: AA, AB,
BB, or ‘‘no call’’. More details on biological specimen collection
and processing, target preparation, scanning, and genotype
generation are provided in [8].
For each subject, the following five variables were also recorded:
age at interview (years), tobacco use (yes/no), alcohol consumption
(yes/no), family history of esophageal cancer (yes/no), and
consumption of pickled vegetables (yes/no).
SNP Array Data Preparation
Before data analyses, we preprocessed the SNP array data
following the approach described in the original paper [8]. First,
out of 11,542 SNPs in the original dataset, 105 SNPs were removed
because they could not be mapped to human genome with NCBI
build 36. Second, to minimize possible genotyping errors, 946 SNPs
were removed because they were homozygous in either cases or
controls. Third, for the same reason, 482 SNPs were removed
because they did not satisfy Hardy-Weinberg equilibrium in the
control group at the a=0.01 level [11]. Fourth, ‘‘recessive A’’
encoding of SNPs (AA=1, AB=0, BB=0) was implemented. After
these steps, the dataset consisted of 10,009 SNPs.
Since some of the data analysis methods (e.g., Principal
Component Analysis or Support Vector Machines described
below) require no missing data, we imputed missing genotypes in
the SNP dataset and used it whenever these methods were
employed. Specifically, we used the multivariate nonparametric
nearest neighbor imputation technique of [12,13].
SNP Selection
First, we employed the SNP selection method described in [8]: For
each SNP, a generalized linear model (GLM) of the probability of
cancer was fit using as predictor variables the SNP and two other
variables: family history of esophageal cancer and alcohol consump-
tion. The GLM was fit for all 100 subjects without leaving out an
independent testing sample. Then a p-value was obtained based on
thedifferencebetweenthedevianceD0ofthenullmodelwithoutany
predictor variables and the deviance D1 of the fitted model. The
difference D0–D1 follows a chi-squared distribution with 3 degrees of
freedom. Since the above procedure is applied to each SNP in the
dataset, it is necessary to adjust for multiple comparisons to ensure
that the desired proportion of false positives (0.05) is preserved. To
this end, Bonferroni adjustment was performed to the significance
level 0.05 of the test (i.e., instead of using the significance level 0.05,
the level 0.05/number of SNPs was used instead). We refer to the
above method as ‘‘GLM1’’. Finally, we note that Bonferroni
adjustment often provides a conservative assessment of the statistical
significance and assumes that all SNPs are independent, while there
exist methods that are less conservative and can be applicable when
the SNPs are dependent, e.g. [14–16].
Since the p-value of GLM1 reflects the combined effect of the
three predictor variables, it tends to be small even if the SNP does
not have any effect on esophageal cancer at all. To address this
problem of the original analysis, we also applied the following
unbiased SNP selection method: we proceed similarly as in GLM1
except that the p-value is based on the difference between the
deviance D’0 of the model including family history of esophageal
cancer and alcohol consumption and the deviance D1. The
resultant statistic D’0–D1 follows a chi-squared distribution with
one degree of freedom, and it reflects the effect of the SNP that is
being analyzed. We refer to this method as ‘‘GLM2’’ and show
that it is indeed unbiased in the Results and Discussion section and
in the Supporting Information File S1.
Finally, when fitting support vector machines (see next section)
to the data, we also applied the Recursive Feature Elimination
(RFE) technique that is among the best performing variable
selection methods for microarray gene expression data and other
high-throughput molecular datasets [17]. In brief, this method
involves iteratively fitting support vector machine cancer classifi-
cation models by discarding the SNPs with the smallest impact on
classification and selecting the SNPs that participate in the best
performing classification model. Unlike the above GLM-based
methods, we applied RFE only to the training set of patients and
controls during cross-validation.
Cancer Classification Models
First, we used the classification procedure described in [8]. That is,
principal component analysis (PCA) was performed on the selected
SNPs, and then the first principal component was extracted and
used to predict cancer status.
As a state-of-the-art alternative to the PCA-based classification
procedure, we applied support vector machine (SVM) classifiers
[18]. The underlying idea of SVM classifiers is to calculate
a maximal margin hyperplane separating the cases and controls.
To achieve non-linear separation, the data are implicitly mapped
to a higher dimensional space by means of a kernel function,
where a separating hyperplane is found. Subjects are classified
according to the side of the hyperplane they belong to. These
classification methods are commonly used for analysis of high-
throughput molecular data [4,19–21] and have many attractive
theoretical and empirical properties. For example, they often
outperform other classification methods to a remarkable degree;
they are also fairly insensitive to the large variable-to-sample ratio;
and they can learn very complex classification functions [18,22].
We used the libSVM implementation of the linear SVM classifiers
(www.csie.ntu.edu.tw/,cjlin/libsvm/). We also experimented
with the nonlinear SVM classifiers but they resulted in more
complex models with similar classification performance.
To assess the combined performance of SNPs and environmental
factors (and/or family history), we used ensemble classification
methods based on SVM classifiers. We present in this paper only
results for the best ensembling technique that averages predictions of
the two SVM classifiers for each subject: one based on SNP data and
another one based on environmental factors (and/or family history).
The description and results for the other ensembling techniques are
provided in the Supporting Information File S2.
Evaluation of Classification Performance
Unlike the original study [8] that used proportion of correct
classifications as the performance metric, we employed area under
the ROC curve (AUC) that has more power to detect predictive
Unbiased Analysis of SNP Data
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versus1-specificityforarangeofclassificationthresholdvalues.AUC
ranges from 0 to 1, with an AUC equal to 0 indicating the worst
possible classifier, 0.5 representing a random (i.e., uninformative)
classifier, and 1 representing perfect classification. An excellent
introduction to ROC analysis for classification is provided in [25].
In order to obtain unbiased AUC estimates, the cancer
classification models were built and evaluated by repeated 10-
fold cross-validation procedure [26]. The repeated 10-fold cross-
validation estimator of classification performance can be obtained
by running regular 10-fold cross-validation procedure 100 times
with different splits of data into training and testing sets and
reporting the average estimate over all 100 runs. This estimator is
asymptotically unbiased because the testing samples are never used
to train the classifier. Furthermore, the repeated 10-fold cross-
validation has much smaller variance than regular cross-validation
that may be affected by a non-representative split of the data [26].
RESULTS AND DISCUSSION
While the prior work reported 37 significant SNPs by applying
method GLM1 to the esophageal cancer SNP array dataset [8],
our execution of the published protocol in [8] leads to 226
significant SNPs. The difference from the reported number of 37
SNPs is due to additional filtering step that was performed to the
set of SNPs significant at the Bonferroni adjusted 0.05 a-level that
was not reported in the original publication (Dr. Maxwell Lee,
personal communication). Since, as we show below, an unbiased
method for SNP effect assessment (e.g., GLM2) yields zero
significant SNPs, any additional filtering step is superfluous,
therefore we do not consider such filtering in the present work.
Nevertheless, the application of the PCA-based classifier to the
data of 226 significant SNPs reproduces the classification
performance of the original study [8]. Namely, the first principal
component provides a nearly perfect classification of patients and
controls with 0.98 AUC and 0.93 proportion of correct
classifications (Figure 1). However, this result is over-optimistic
primarily due to the following reasons.
First, the calculation of p-value in SNP selection method GLM1
does not reflect the significance of the SNP under consideration,
but the significance of three variables combined (SNP, family
history of esophageal cancer, and alcohol consumption). Because
family history and alcohol consumption are strong risk factors for
esophageal cancer, this p-value will be biased towards zero, even
when the SNP has nothing to do with esophageal cancer. This bias
can be demonstrated as follows: It is reasonable to assume the
majority of the SNPs do not have any effect on esophageal cancer
risk. For these SNPs, the p-values should follow a uniform
distribution between 0 and 1. However, a vast majority of their p-
values were ,10
23 (Figure 2), which is consistent with the fact that
their p-value reflected the combined effect of family history of
esophageal cancer, alcohol consumption, and the SNP instead of
the SNP itself. On the other hand, the procedure GLM2 reflects
the effects of only SNPs and does not suffer from the above
shortcoming (Figure 2). A more elaborate empirical permutation-
based demonstration of why GLM1 is biased while GLM2 is not is
provided in the Supporting Information File S1. The application
of procedure GLM2 resulted in no significant SNPs after
Bonferroni adjustment (Figure 2). Therefore, the SNPs reported
in [8] as statistically significant are not statistically significant at the
Bonferroni adjusted 0.05 a-level.
Second, both SNP selection by GLM1 and building of PCA-
based classifier model were performed in [8] on the same 100
subjects as used for estimation of final classification accuracy.
Since neither cross-validation nor independent sample validation
Figure 1. First two principal components extracted from SNPs that were selected by the method GLM1. The first principal component provides
a nearly perfect separation of cases from controls.
doi:10.1371/journal.pone.0000958.g001
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is overoptimistic as explained in [27,28]. In order to obtain an
unbiased performance estimate for the SNP selection method and
classifier of [8], the above methods were applied by repeated 10-
fold cross-validation. The resulting classification performance
estimate was 0.68 AUC, while the original procedure in [8] led
to 0.98 AUC, indicating a 0.30 AUC over-estimation.
To assess the contribution of SNPs and other variables to
esophageal cancer classification, we performed several analyses
that are summarized in Table 1. We used the SNP selection
technique RFE [17] and the SVM classifiers [18] described in the
Materials and Methods section. When SNP data is used alone, the
performance is 0.51 AUC which is statistically indistinguishable
from the performance of an uninformative classifier (0.50 AUC).
On the other hand, four environmental variables alone (age at
interview, tobacco use, alcohol consumption, and consumption of
pickled vegetables) can classify cancer with 0.60 AUC indicating
a modest association with cancer. When these four environmental
variables are combined with SNP data, the resulting performance
slightly increases to 0.62 AUC. An even more surprising result was
that a single variable (i.e., family history of esophageal cancer) can
classify the disease with 0.66 AUC which is more accurate than
using SNP data and the four other environmental variables. We
hypothesize that this happens because the family history contains
information about other environmental and genetic variables that
were not measured in the study data. Clearly, there are much
more than four environmental variables that affect esophageal
cancer. Likewise the Affymetrix 10k SNP array is an early
genotyping technology that does not provide as dense genomic
coverage as more recent arrays with .500k SNPs [29,30]. When
the family history is combined with other four environmental
variables, cancer can be classified with 0.73 AUC which is more
accurate than using either set of variables alone. On the other
hand, when the family history is combined with SNP data, the
resulting classifier with 0.64 AUC is not as accurate as using the
former variable alone. Finally, when SNPs and all other variables
are combined, cancer can be classified with 0.73 AUC.
The experiments presented in this paper involved SVM
classifiers. As we mentioned, the choice of classifier was based
on empirical evidence suggesting that SVMs have superior perfor-
mance in different high-dimensional ‘‘omics’’ datasets [19–21] as
Figure 2. Distribution of p-values computed by GLM1 and GLM2 SNP selection methods. The figure is shown in logarithmic scale for convenience.
The vertical line is the Bonferroni adjusted a-level (0.05/10,009). While there are SNPs that are significant according to GLM1 method, no SNP is
significant by GLM2. The distribution of p-values for GLM2 is uniform, however the distribution for GLM1 is not.
doi:10.1371/journal.pone.0000958.g002
Table 1. Estimates of classification performance obtained by
repeated 10-fold cross-validation procedure.
......................................................................
Data used for the classifier Classification performance (AUC)
{SNPs} 0.51
{Alc, Smk, Age, Pck} 0.60
{Fh} 0.66
{Fh, Alc, Smk, Age, Pck} 0.73
{SNPs}+{Alc, Smk, Age, Pck} 0.62
{SNPs}+{Fh} 0.64
{SNPs}+{Fh, Alc, Smk, Age, Pck} 0.73
The classification algorithm is Support Vector Machines (SVM). Only SNPs
selected by Recursive Feature Elimination (RFE) are used. The following
abbreviations are used for variable names: Age (age at interview), Smk (tobacco
use), Alc (alcohol consumption), Fh (family history of esophageal cancer), and
Pck (consumption of pickled vegetables). The ‘‘+’’ symbol in the Data column
denotes that the analysis was performed by ensembling approach.
doi:10.1371/journal.pone.0000958.t001
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unsupervised classification methods such as PCA [27,28].
However, one cannot preclude that there does not exist some
classification methods that outperform SVMs in SNP array
datasets. Future research will answer this question.
In conclusion, our findings suggest that several data analysis
pitfalls of [8] led researchers to identify SNPs that are not
statistically significant and to derive a severely biased estimate of
classification performance of esophageal cancer patients and
healthy controls on the basis of these SNPs. We also showed that
environmental factors and especially family history of cancer (the
latter may serve as proxy to both genetic and environmental
factors) have a modest association with the disease. It is thus
conceivable that other SNPs, not included in the assay employed,
may be implicated in the disease. These results are consistent with
the previous literature that emphasizes the importance of
environmental factors on the causation of this complex disease
[9,10]. The results also underscore the importance of sound data
analysis in genome-wide association studies.
SUPPORTING INFORMATION
File S1 Demonstration of Bias in Computation of P-Values
Found at: doi:10.1371/journal.pone.0000958.s001 (0.08 MB
DOC)
File S2 Integrated Analysis of Multiple Data Types
Found at: doi:10.1371/journal.pone.0000958.s002 (0.09 MB
DOC)
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